Try our corporate solution for free!

Expected acquisitions of biopharma companies by type of asset 2021

Expected targets of biopharmaceutical acquisitions in 2021, by asset type

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2021

Region

United States

Survey time period

November 19, 2020, to December 30, 2020

Number of respondents

286 respondents

Special properties

U.S. healthcare and life sciences investment professionals

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Pharma and biotech M&A activity "

Statistics on Pharma and biotech M&A activity

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

16
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.